Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Modified pigment epithelium-derived factor (PEDF) peptides and uses thereof for treating neovascular diseases, inflammatory diseases, cancer, and for cytoprotection

Modified pigment epithelium-derived factor (PEDF) peptides and uses thereof for treating neovascular diseases, inflammatory diseases, cancer, and for cytoprotection

US Patent 11261237 · Granted Mar 1, 2022

Estimated economic value: $214,119,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Nanocarriers having surface conjugated peptides and uses thereof for sustained l2021
Nanocarriers having surface conjugated peptides and uses thereof for sustained l2021
Nanocarriers having surface conjugated peptides and uses thereof for sustained l2020
Nanocarriers having surface conjugated peptides and uses thereof for sustained l2020
Modified pigment epithelium-derived factor (PEDF) peptides and uses thereof for 2018
Modified pigment epithelium-derived factor (PEDF) peptides and uses thereof for 2018
Modified pigment epithelium-derived factor (PEDF) peptides and uses thereof for 2018
Modified pigment epithelium-derived factor (PEDF) peptides and uses thereof for 2018
Methods and compositions for inhibiting angiogenesis2015
Methods and compositions for inhibiting angiogenesis2012
Amphiphilic polymer-protein conjugates and methods of use thereof2012
Amphiphilic polymer-protein conjugates and methods of use thereof2011